SOPHiA GENETICS SA Free Cash Flow (FCF) History (SOPH)

SOPHiA GENETICS SA reported −$36.5M in free cash flow for fiscal 2025, an increase of $8.3M from the previous fiscal year, with a free cash flow margin of −47.19%.

View full SOPHiA GENETICS SA company overview

SOPHiA GENETICS SA free cash flow by year

SOPHiA GENETICS SA annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−$36.5M$8.3M−47.19%
20242024-12-31−$44.8M$10.0M−68.68%
20232023-12-31−$54.7M$19.5M−87.73%
20222022-12-31−$74.2M−$13.6M−155.99%
20212021-12-31−$60.6M−$28.4M−149.87%
20202020-12-31−$32.2M$855,000−113.31%
20192019-12-31−$33.0M−130.25%

SOPHiA GENETICS SA free cash flow growth trends

Over the last five reported fiscal years, free cash flow declined from −$32.2M to −$36.5M, a net decrease of $4.3M.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review SOPHiA GENETICS SA filings at SEC.gov ↗